Can Sinaptica Slow Alzheimer’s Painful Decline; Heidi Dohse on patient-centered design
Failed to add items
Add to basket failed.
Add to Wish List failed.
Remove from Wish List failed.
Follow podcast failed
Unfollow podcast failed
Can Sinaptica Slow Alzheimer’s Painful Decline; Heidi Dohse on patient-centered design
-
Narrated by:
-
By:
About this listen
In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi hears encouraging news from Ken Mariash, CEO of Sinaptica Therapeutics, a neuromodulation company developing a TMS system that may be able to slow the advance of Azheimer’s. Mariash paints a hopeful picture for people - and families - fearing this dreadful disease.
In our Future of MedTech Opportunities (FOMO) interview, DeviceTalks’ Emira Wininger talks with Heidi Dohse, founder and president of Tour de Heart. Dohse has used a pacemaker for nearly all of her life and brings important insights on the importance of patient design.
This episode is brought to you by Interpower Corp. Go to Interpower.com for more information.
Thank you for listening to this episode of the DeviceTalks Weekly Podcast.
***
Enjoy this podcast? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.
Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe